JM
Jason McCarthy Maxim Group Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
51
Kiora Pharmaceuticals
KPRX
$9.23M
| $2.63 | $900 |
34,121%
upside
| Buy |
19 Jan ‘22
3 years ago |
|
52
Acurx Pharmaceuticals
ACXP
$6.54M
| $4.19 | $240 |
5,628%
upside
| Buy |
29 Nov ‘21
3 years ago |
|
53
Performance Technologies
PTIX
$2.47M
| $2.86 | $224 |
7,732%
upside
| Buy |
29 Oct ‘21
3 years ago |
|
|
ETHZ
54
ETHZilla Corporation Common Stock
ETHZ
$404M
| $2.44 | $4,180 |
171,211%
upside
| Buy |
15 Sep ‘21
4 years ago |
|
55
Enveric Biosciences
ENVB
$2.92M
| $0.8803 | $4,500 |
511,089%
upside
| Buy |
28 Jun ‘21
4 years ago |
|
56
MindMed
MNMD
$714M
| $9.77 | $90 |
821%
upside
| Buy |
28 Jun ‘21
4 years ago |
|
57
Clene
CLNN
$66.2M
| $6.60 | $360 |
5,355%
upside
| Buy |
20 May ‘21
4 years ago |
|
58
Avalo Therapeutics
AVTX
$150M
| $11.61 | $7 |
40%
downside
| Buy |
21 Apr ‘21
4 years ago |
|
59
Fennec Pharmaceuticals
FENC
$251M
| $9.22 | $12 |
30%
upside
| Buy |
19 Apr ‘21
4 years ago |
|
60
MediciNova
MNOV
$61.8M
| $1.28 | $15 |
1,072%
upside
| Buy |
10 Mar ‘21
4 years ago |
|
61
Cassava Sciences
SAVA
$103M
| $2.18 | $80 |
3,570%
upside
| Buy |
16 Feb ‘21
4 years ago |
|
62
Galapagos
GLPG
$2.21B
| $32.67 | $170 |
420%
upside
| Buy |
19 Nov ‘20
4 years ago |
|
63
DiaMedica Therapeutics
DMAC
$370M
| $7.21 | $14 |
94%
upside
| Buy |
8 Jul ‘20
5 years ago |
|